Piperidine derivatives useful as orexin receptor antagonists

Details for Australian Patent Application No. 2008270294 (hide)

Owner Glaxo Group Limited

Inventors Amantini, David; Belvedere, Sandro; Alvaro, Giuseppe

Agent Davies Collison Cave

Pub. Number AU-A-2008270294

PCT Pub. Number WO2009/003993

Priority 0804317.6 07.03.08 GB; 0712887.9 03.07.07 GB

Filing date 1 July 2008

Wipo publication date 8 January 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2009/003993 Priority application(s): WO2009/003993

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008270295-Shutoff valve integrated into a pressure regulator

2008270285-Supplemention of maternal diet